Skip to main content
. 2020 May;18(5):348–407. doi: 10.2174/1385272823666191021124443

Fig. (33).

Fig. (33)

New clioquinol-roflumilast/rolipram hybrids 79 designed as multi-target ligands for AD and structures of compounds 79a and 79b as the most active PDE4 inhibitors with memory improving properties.